In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain the term ...

Genomics England began as a vessel to execute the UK Government's bold plan to sequence 100,000 whole genomes and incorporate genomic medicine into routine care in the NHS, a feat we achieved in 2018 ...

The Genomics England Research Seminar series is a season of events held to demonstrate the best research from Genomics England and our partners. They started in October 2018, and are monthly, ...

The Genome Analysis team at Genomics England are working to develop cutting-edge genome analysis approaches to apply in the clinic. They aim to enable world-leading personalised healthcare that is ...

In this explainer episode, we’ve asked John Pullinger, Senior Bio Sample Operations Manager at Genomics England, to explain what it means to go on a diagnostic odyssey. You can also find a series of ...

At Genomics England, we hold data for over 15,000 participants with cancer in the National Genomic Research Library (NGRL). Whole genome sequencing for these participants can lead to improvements in ...

At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what it means to go on a diagnostic odyssey. The term ‘odyssey’ ...

New research has identified a novel mechanism driving osteosarcoma – an aggressive paediatric bone cancer – providing insights to help predict patient outcomes and improve the condition’s management.

The Machine Learning team use machine learning and advanced data analytics to support progress for patients and research partners. Researchers and clinicians detect conditions by using different kinds ...

There is a need for more research in sickle cell Historically, research in sickle cell has not been prioritised. Because of this, there aren’t many treatment options for people living with the ...